As demonstrated in our previous study, the treatment of the T2DM mice with Hsp–Cu(II) resulted in a significant decrease in the levels of IL-1β, IL-6, and TNF-α [27]. The gene discussed is IL1B; the disease is type 2 diabetes mellitus.